Mumbai: Private equity firm InvAscent is preparing to list five portfolio companies across health and pharmaceuticals…
Tag: InvAscent
InvAscent looks to exit Aizant Drug at $350-400 mn valuation
Healthcare-focused private equity firm InvAscent is looking to sell its stake in Aizant Drug Research Solutions…